Toyond's alliance is your alliance
Toyond is a global, innovation-led, natural-based company active in Nutrition, Health and Sustainable Future. Our mission is to drive natural worthy with innovation.
We offer single and packages of solutions that benefit our customers and make lives brighter, spanning from human nutrition, animal nutrition, to natural plant extracts, natural pigments, vitamins, and RNA molecular diagnostics in the field of oncology, etc.
With 10 global offices to fulfill our client needs from cultivation, manufacturing, private label, customer service and retail. Our branch offices in North America, Europe, Oceania, and Southeast Asia are all have the local service team and local warehouse. We provide customers all over the world with consecutive quality service 7 days 24 hours per week.
The world’s leading producer and innovator of natural astaxanthin AstaMAZ is part of the Toyond Group. AstaMaz is a microalgae innovating company servicing globally. Our natural astaxanthin is cultivated, harvested, and extracted in New Zealand. As the global demand for natural astaxanthin continues to grow, we will continue to be fully dedicated to ensuring the supply of premium, natural astaxanthin products.
At VitaSource, our innovation is fueled by our ability to understand how food and nutrients' unique properties can be combined to unlock their true potential. Our supplement-ready formulations combine the earth's best nutrition with our clinical innovation, through years of research and extensive testing. Similarly, our organization's success is driven by our ability to synergize the unique capabilities of each chain of supply.
We’ve always believed in the synergy that exists between the earth’s best ingredients and scientific ingenuity. Over the years, we’ve developed a number of proprietary technologies and patented products that are as much a result of human wonder as they are of nature.
Canhelp Genomics is a leading healthcare company focused on molecular diagnostics & personalized medicine in the field of oncology. Dedicated to developing cutting-edge diagnostics, Canhelp Genomics improves patient care by resolving diagnostic uncertainty with evidence that is trustworthy and actionable. The company's products uniquely combine genomic technology, clinical science and bioinformatics solution to generate insights that can help the accurate diagnosis of disease and help physicians match patients to more personalized treatment options.With approximately 3~5% of all newly diagnosed cancers presenting without an identifiable primary site. We believe our Canhelp-Origin, a novel molecular diagnostic test offering accurate, highly reliable molecular information for cancer of unknown primary.
We believe that our accurate and proprietary bioinformatics technologies provide Canhelp Genomics with a key competitive advantage in the molecular diagnostics and personalized medicine. In addition to Canhelp-Origin for metastatic tumors, we are also developing a series of genomic products, which are improving the diagnosis of kidney cancer and lung cancer addressing key unmet clinical needs in oncology. These three genomic tests can aid in the reduction of unnecessary repeat biopsies and ineffective treatment.